Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain Participants
Clinical trial NCT00805142 · COMPLETED
Trial details
- NCT number
- NCT00805142
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2009-07-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.